Tunneling nanotube formation is stimulated by hypoxia in ovarian cancer cells
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
// Snider Desir 1, 2, * , Elizabeth L. Dickson 3, * , Rachel I. Vogel 4 , Venugopal Thayanithy 2 , Phillip Wong 2 , Deanna Teoh 3 , Melissa A. Geller 3 , Clifford J. Steer 5 , Subbaya Subramanian 6 , Emil Lou 1, 2 1 Integrative Biology and Physiology Program, University of Minnesota, Minneapolis, MN, USA 2 Department of Medicine, Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN, USA 3 Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University of Minnesota, Minneapolis, MN, USA 4 Biostatistics and Bioinformatics Core, Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA 5 Departments of Medicine and Genetics, Cell Biology and Development, University of Minnesota, Minneapolis, MN, USA 6 Department of Surgery, Division of Basic Science and Translational Research, University of Minnesota, Minneapolis, MN, USA * These authors contributed equally to this work and are co-first authors Correspondence to: Emil Lou, email: emil-lou@umn.edu Keywords: tunneling nanotubes, intercellular communication, hypoxia, chemoresistance, mTOR Received: November 04, 2015 Accepted: April 24, 2016 Published: May 20, 2016 ABSTRACT In this study, we demonstrated that hypoxic conditions stimulated an increase in tunneling nanotube (TNT) formation in chemoresistant ovarian cancer cells (SKOV3, C200).We found that suppressing the mTOR pathway using either everolimus or metformin led to suppression of TNT formation in vitro , verifying TNTs as a potential target for cancer-directed therapy. Additionally, TNT formation was detected in co-cultures including between platinum-resistant SKOV3 cells, between SKOV3 cells and platinum-chemosensitive A2780 cells, and between SKOV3 cells cultured with benign ovarian epithelial (IOSE) cells; these findings indicate that TNTs are novel conduits for malignant cell interactions and tumor cell interactions with other cells in the microenvironment. When chemoresistant C200 and parent chemosensitive A2780 cells were co-cultured, chemoresistant cells displayed a higher likelihood of TNT formation to each other than to chemosensitive malignant or benign epithelial cells. Hypoxia-induced TNT formation represents a potential mechanism for intercellular communication in ovarian cancer and other forms of invasive refractory cancers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Samanta, D., Gilkes, D. M., Chaturvedi, P., Xiang, L., & Semenza, G. L. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1421438111 · Cited by 460 · cited 1×
“Hypoxia is a hallmark of aggressively proliferating malignant tumors, and has been implicated in the development of chemoresistance [19, 20].”
BackgroundRetractedSiegel, R., Ma, J., Zou, Z., & Jemal, A. (2014) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21208 · Cited by 11,499
Nanotubular Highways for Intercellular Organelle Transport
Rustom, A., Saffrich, R., Markovic, I., Walther, P., & Gerdes, H.-H. (2004) · Science · doi:10.1126/science.1093133 · Cited by 2,038 · cited 2×
“They are distinguished from other actinbased cellular extensions by their smaller diameter (50–800 nm) and non-adherence to the substratum when cultured in vitro [9, 10, 14, 15].”
BackgroundDelivery of chemotherapeutic drugs in tumour cell-derived microparticles
Tang, K., Zhang, Y., Zhang, H., Xu, P., Liu, J., Ma, J., Lv, M., Li, D., Katirai, F., Shen, G.-X., et al. (2012) · Nature Communications · doi:10.1038/ncomms2282 · Cited by 453
Lou, E., Fujisawa, S., Morozov, A., Barlas, A., Romin, Y., Dogan, Y., Gholami, S., Moreira, A. L., Manova-Todorova, K., & Moore, M. A. S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033093 · Cited by 420
Self-citationZhu, D., Tan, K. S., Zhang, X., Sun, A. Y., Sun, G. Y., & Lee, J. C.-M. (2005) · Journal of Cell Science · doi:10.1242/jcs.02507 · Cited by 264
Cited by
The power and potential of mitochondria transfer
Borcherding, N., & Brestoff, J. R. (2023) · Nature · doi:10.1038/s41586-023-06537-z · Cited by 514
Intercellular mitochondrial transfer as a means of tissue revitalization
Liu, D., Gao, Y., Liu, J., Huang, Y., Yin, J., Feng, Y., Shi, L., Meloni, B. P., Zhang, C., Zheng, M., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00440-z · Cited by 403
Chen, X., Zhou, J., Li, X., Wang, X., Lin, Y., & Wang, X. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.08.001 · Cited by 287
Chen, X., Ying, X., Wang, X., Wu, X., Zhu, Q., & Wang, X. (2017) · Oncology Reports · doi:10.3892/or.2017.5697 · Cited by 269
Lu, J., Zheng, X., Li, F., Yu, Y., Chen, Z., Liu, Z., Wang, Z., Xu, H., & Yang, W. (2017) · Oncotarget · doi:10.18632/oncotarget.14695 · Cited by 185
Nasoni, M. G., Carloni, S., Canonico, B., Burattini, S., Cesarini, E., Papa, S., Pagliarini, M., Ambrogini, P., Balduini, W., & Luchetti, F. (2021) · Journal of Pineal Research · doi:10.1111/jpi.12747 · Cited by 135
Rhes travels from cell to cell and transports Huntington disease protein via TNT-like protrusion
Sharma, M., & Subramaniam, S. (2019) · Journal of Cell Biology · doi:10.1083/jcb.201807068 · Cited by 76
Omsland, M., Pise-Masison, C., Fujikawa, D., Galli, V., Fenizia, C., Parks, R. W., Gjertsen, B. T., Franchini, G., & Andresen, V. (2018) · Scientific Reports · doi:10.1038/s41598-018-29391-w · Cited by 71
Zhou, C., Huang, M., Wang, S., Chu, S., Zhang, Z., & Chen, N. (2024) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2024.110921 · Cited by 34
Metadata
- Authors
- Desir, S., Dickson, E. L., Vogel, R. I., Thayanithy, V., Wong, P., Teoh, D., Geller, M. A., Steer, C. J., Subramanian, S., & Lou, E.
- Venue
- Oncotarget
- Publisher
- Impact Journals, LLC
- Published
- 2016-05-20
- Volume
- 7
- Issue
- 28
- Pages
- 43150-43161
- ISSN
- 1949-2553 (ISSN-L)
- OpenAlex
- W2395316926
- Cited by
- 152
- References
- 6
- FWCI
- 5.72
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.